PLANO, Texas, Nov. 21, 2016 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company,
announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Financial Officer, are scheduled to present at
the 28th Annual Piper Jaffray Healthcare Conference in New York, NY. Management will also be available for one-on-one
meetings at the conference.
| Event: |
|
28th Annual Piper Jaffray Healthcare Conference |
| Format: |
|
Presentation and One-on-One Meetings |
| Date: |
|
Wednesday, November 30th, 2016 |
| Time: |
|
3:20 pm ET |
| |
|
|
A webcast of the Company’s presentation will be available by visiting the investor relations section of Nuvectra’s website at
www.nuvectramed.com. A webcast replay of the presentation will be available for 90 days.
About Nuvectra Corporation
Nuvectra™ is a neurostimulation company committed to helping physicians improve the lives of people with chronic
neurological conditions. The Algovita® Spinal Cord Stimulation (SCS) System is our first commercial offering and is CE marked and
FDA approved for the treatment of chronic pain of the trunk and/or limbs. Our innovative technology platform also has capabilities
under development to support other neurological indications such as sacral nerve stimulation (SNS), and deep brain stimulation
(DBS). In addition, our NeuroNexus subsidiary designs, manufactures and markets leading-edge neural-interface technologies for the
neuroscience clinical research market. Visit the Nuvectra website at www.nuvectramed.com.
Company Contacts: Nuvectra Corporation Walter Berger, Chief Financial Officer (214) 474-3102 wberger@nuvectramed.com Jennifer Armstrong, Media Relations (214) 474-3110 jarmstrong@nuvectramed.com Investor Contacts: The Ruth Group Nick Laudico (646) 536-7030 nlaudico@theruthgroup.com Zack Kubow (646) 536-7020 zkubow@theruthgroup.com
